Clinical Study

Stability of Facial Affective Expressions in Schizophrenia

Table 1

Patient characteristics.

GenderAgePsychosis diagnosedSchizophrenia diagnosedType of schizophreniaMedication interv. A1, B1, C1Medication interview A2

M2719921997Paranoid 295.30RisperidoneRisperidone
M4019871989Paranoid 295.30OlanzapineRisperidone
M3219912000Undiff. 295.90PerphenazinePerphenazine
M5219671971Paranoid 295.30ZuclopenthixolZuclopenthixol
M3619941994Paranoid 295.30OlanzapineOlanzapine
F4819851985Paranoid 295.30ZuclopenthixolZuclopenthixol
F5219721982Paranoid 295.30ZiprasidoneNone
M2719981998Catatonic 295.20OlanzapineOlanzapine